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Sildenafil alters biogenic amines and increases oxidative damage 
in brain regions of insulin-hypoglycemic rats
The aim of the present study was to determine the effect of 
sildenafil on dopamine, 5-hydroxyindol acetic acid (5-HIAA) 
and selected biomarkers of oxidative stress in the brain of 
hypoglycemic rats. The animals were treated intraperitoneally 
as follows: group 1 (control), saline solution; group 2, insulin 
(10 U per rat or 50 U kg–1); group 3, insulin + single dose of 
sildenafil (50 U kg–1 + 50 mg kg–1); group 4, insulin + three 
doses of sildenafil every 24 hours (50 U kg–1 + 50 mg kg–1). In 
groups 2, 3 and 4, insulin was administered every 24 hours 
for 10 days. Blood glucose was measured after the last treat-
ment. On the last day of the treatment, the animals´ brains 
were extracted to measure the levels of oxidative stress 
markers [H2O2, Ca2+,Mg2+-ATPase, glutathione and lipid 
peroxidation (TBARS)], dopamine and 5-HIAA in the cortex, 
striatum and cerebellum/medulla oblongata by validated 
methods. The results suggest that administration of insulin 
in combination with sildenafil induces hypoglycemia and 
hypotension, enhances oxidative damage and provokes chan-
ges in the brain metabolism of biogenic amines. Administra-
tion of insulin and sildenafil promotes biometabolic responses 
in glucose control, namely, it induces hypoglycemia and hy-
po tension. It also enhances oxidative damage and provokes 
changes in the brain metabolism of biogenic amines.
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Obesity increases the risk of atherosclerosis, renal diseases, vesicular lithiasis and 
diabetes. In the last few decades, type 2 diabetes mellitus has reached epidemic proportions 
due to bad lifestyles (1). In recent times, multiple drugs for effective management of obesity 
have emerged but most of them confer only modest benefits for patients. The majority of 
patients require insulin to control diabetes; however, insulin may provoke hypoglycemic 
conditions in patients with this pathology (2). Erectile dysfunction (ED) associated with 
type 2 diabetes is a severe problem, which requires effective treatment (3). Most adult 
patients, irrespective of age, will require sildenafil as an option for this dysfunction and it 
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has recently become the preferred treatment of choice (4). Effects of sildenafil on the 
pulmonary vasculature and on erectile dysfunction are increasingly well understood (5); 
nevertheless, its mechanism in hypoglycemic patients is still unknown.
On the other hand, obesity and overweight have been associated with an increase in 
free radicals (FR) (6), which can put the cells of the central nervous system (CNS) in danger 
of oxidative damage caused by excessive production of oxygen reactive species involved 
in many pathological processes (7). Oxidative stress dysregulates energy and glucose ho-
meostasis in different brain regions and disrupts brain circuits such as the dopaminergic 
system (8).
Plasma membrane phospholipids in neurons are in close contact with structural pro-
teins embedded in the lipid bilayer, from which Na+,K+-ATPase is responsible for keeping 
the ionic interchange through this bilayer by stimulating Na+ and K+ flows. Inhibition of 
Na+,K+-ATPase activity alters the ionic interchange within the CNS (9).
In view of the above, the purpose of the present study was to evaluate the effect of 
sildenafil on the levels of dopamine and 5-HIAA monoamines, and selected oxidative 
stress markers in brain regions of young rats with insulin induced hypoglycemia.
EXPERIMENTAL
The study included twenty-eight male Wistar rats of 7 weeks of age and 200 g mean 
body mass. During the study, all animals were kept in closed boxes under a light:dark period 
of 12:12 h. Animals were divided into four groups of 7 rats each and treated intraperitoneally 
as follows: group 1 (control), 0.9 % NaCl; group 2, insulin (10 U per rat or 50 U kg–1); group 3, 
insulin (50 U kg–1) + single dose of sildenafil (50 mg kg–1); group 4, insulin (50 U kg–1) + three 
doses of sildenafil (50 mg kg–1) every 24 hours. Treatment groups received insulin every 24 
hours for 10 days. Groups 2–4 were treated every day with insulin for 10 days. Group 3 
received sildenafil once, on day 10. Group 4 received sildenafil three times, namely, on days 
8, 9 and 10, each 24 hours. Sixty minutes after receiving the last treatment, animals’ blood 
was taken from the tail and used to measure their glucose levels. Animals were sacrificed 
by decapitation without anesthesia. Brains were extracted and immediately placed in a 0.9 
% cold NaCl solution. They were later divided into the cortex, cerebellum/medulla oblongata 
and striatum. Tissues from these brain regions were then homogenized in a 0.05 mol L–1 
phosphate buffer solution (PBS) and used to quantify 5-hydroxyindol acetic acid (5-HIAA), 
dopamine, Ca2+,Mg2+-ATPase, H2O2, lipid peroxidation and glutathione (GSH) using 
previously validated methods (10). All samples were frozen at –20 °C until analysis.
Animal experiments were carried out in strict compliance with the Guidelines for 
Ethical Control and Supervision in the Care and Use of Animals and all experimental 
procedures were conducted following national and international rules. Also, the study 
was approved by the Laboratory Animals Use and Care Committee of the National 
Institute of Pediatrics, Ciudad de México, México.
Statistical analysis
Two-way ANOVA and Tukey ś test were used in the analysis of the results while the 
statistical Dunnett’s test was employed for Kramer HSD (honestly significant difference) 
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for comparison of all pairs. For all tests, values of p < 0.05 were considered statistically 
significant. Statistical Software JMP version 8.0.0 for academic purposes was used.
RESULTS AND DISCUSSION
Administration of insulin alone or in combination with sildenafil in single or repeated 
doses decreased the levels of glucose in a significant way (p < 0.0001) compared to the 
control group. Comparison among the experimental groups showed that the group treated 
with insulin + sildenafil in repeated doses had the biggest decrease in glucose levels, which 
in the group treated with insulin alone showed to be significantly different (Table I).
Table I. Levels of glucose in the blood of animals treated intraperitoneally either with insulin, sildenafil or both 
Group/treatment Glucose (mg per 100 mL)
Control (saline) 110.50 ± 7.56
Insulin (50 U kg–1) 57.83 ± 4.96*
Insulin (50 U kg–1) + sildenafil (50 mg kg–1) – single dose 48.57 ± 7.50*
Insulin (50 U kg–1) + sildenafil (50 mg kg–1) – 3 doses 46.57 ± 4.04*,**
Average ± SD, n = 7.
Statistically significant difference: *p < 0.0001 vs. control, **p = 0.017 vs. insulin.
In the cortex, administration of insulin alone or combined with sildenafil produced a 
significant decrease in the levels of lipid peroxidation (TBARS – thiobarbituric acid reactive 
substances) compared to the control group (Table II).
A similar pattern was observed in the striatum; however, only in group 4 treated with 
repeated doses of sildenafil, TBARS level was significantly different from the control group 
although it was not different at all from the groups treated with insulin or a single dose of 
insulin + sildenafil (Table III).
In the cerebellum/medulla oblongata, a significant decrease was observed in the 
groups treated with a combination of insulin and sildenafil, both in single and repeated 
doses, compared to the control (Table IV). Similarly to what was observed in the cortex, the 
group that received repeated doses of insulin + sildenafil showed a larger decrease in the 
level of TBARS, which was significantly different from the group treated with a single dose 
of insulin + sildenafil (Table II).
In the cortex, groups 2 and 3 showed a significant decrease in the levels of H2O2; in the 
striatum, however, a discrete increase which was not significant was observed in the 
experimental groups compared to the control group. With regard to cerebellum/medulla 
oblongata, all groups showed a significant decrease in the levels of H2O2 compared to the 
control. Again, group 4 treated with repeated doses of sildenafil manifested a greater 
decrease in H2O2 levels, which was significant compared to the group treated with insulin 
alone.
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In the cortex and striatum, statistical 
analysis of the effects of insulin alone or 
combined with single or repeated doses 
of sildenafil on the levels of GSH did not 
reveal significant changes compared to 
the control group. In the cerebellum/
medulla oblongata, a significant increase 
was observed in the levels of this biogenic 
amine in the groups treated with insulin 
alone and group 4 with repeated doses of 
sildenafil, compared to the control group.
Statistical analysis of the data reve-
aled a significant increase in the levels of 
5-HIAA in the cortex of group 4 treated 
with insulin + repeated doses of sildenafil 
compared to the control. Groups treated 
with the combination of insulin + silde-
nafil in both treatment schemes showed a 
decrease in the levels of 5-HIAA com-
pared to the group that received insulin 
alone. In the striatum and cerebellum/
medulla oblongata, the analysis did not 
reveal any significant changes in the 
concentration of 5-HIAA. Administration 
of insulin + sildenafil in repeated doses 
produced a decrease in the concentration 
of dopamine (DA) in the cortex, which was 
statistically significant only compared to 
the group that received insulin alone. In 
other regions of the brain, no changes in 
the concentration of DA were observed.
In the case of ATPase activity, the 
administration of insulin alone or com-
bined with sildenafil increased signi fi-
cantly the activity of amine in the cortex 
and striatum. However, in the cerebellum/
medulla oblongata, this increase was sta tis-
tically significant only for group 4 treated 
with insulin + repeated doses of sildenafil 
compared to the control and the group 
that received a single dose of in su lin + 
sildenafil.
A major issue in glycemic control in 
neurocritical care is the lack of continuous 
glucose monitoring in patients under 
insulin therapy. Thus, these patients are 
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associated with higher rates of hypoglycemia without a chance to improve their survival 
rate. This may probably be the reason why Bilotta and Rossa (11) recommended adequate 
nutrition before and during insulin infusion.
In this work, dopamine and 5-HIAA led to a significant decrease in the cortex regions. 
These findings coincide with that of Ammon-Treiber et al. (12) who suggest that decreased 
levels of DA and 5-HIAA can aggravate neurotoxic effects on the hypoxia/hypoglycemia 
model, and that their metabolites may increase oxidative damage to the brain.
Hypoglycemic animals exerted a decrease in the levels of glutathione, suggesting that 
insulin and sildenafil provide no protection from oxidative stress to the brain. Hence, such 
doses of insulin and sildenafil may make the CNS vulnerable to damage by oxidative 
stress caused by depletion of the glutathione antioxidant. NO production in selected 
neuron populations may have induced oxidative stress (13), which altered GSH metabolism 
in the brain.
Suppression of reactive oxygen species-dependent pathways in the endothelium 
restores insulin delivery to peripheral organs by preserving nitric oxide (NO) availability. 
The lipoperoxidation and H2O2 levels decreased as a consequence of sildenafil and insulin 
treatment. This result is in accord with what was previously reported in our laboratories 
where hypoglycemia was associated with increased oxidative damage (14).
Animals treated with insulin and sildenafil experienced an increase in total ATPase 
in the cortex and striatum. This finding agrees with the report of Filippov (15), who 
suggested an increase in the number of active molecules of ATPase under the influence of 
membrane structural changes in the hypoglycemic state. There was a decrease in blood 
glucose in the animals that received sildenafil, thus confirming the hypoglycemia model 
and a potential increase of oxidative damage with the use of this drug. This concurs with 
Mandosi et al. (16) who found out that sildenafil exerted a beneficial effect on glycometabolic 
control in type 2 diabetes by increasing insulin sensitivity (17). Moreover, the combination 
of sildenafil and insulin may offer an improved cerebrovascular response (18), due to its 
relaxation action on corpora cavernosa.
CONCLUSIONS
Administration of insulin and sildenafil promoted biometabolic responses in glucose 
control. Hypoglycemic animals showed a decrease in the levels of glutathione suggesting 
that insulin and sildenafil provided no protection from oxidative stress to the brain. Hence, 
such doses of insulin and sildenafil may make the CNS vulnerable to damage caused by 
oxidative stress due to depletion of the glutathione antioxidant.
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